HI

Hidenori Ichijo

LR Ludwig Institute For Cancer Research: 5 patents #106 of 611Top 20%
CB Creative Biomolecules: 2 patents #19 of 47Top 45%
JR Japanese Foundation For Cancer Research: 1 patents #37 of 125Top 30%
TL Takeda Pharmaceutical Company Limited: 1 patents #859 of 1,531Top 60%
TT The University Of Tokyo: 1 patents #1,000 of 2,633Top 40%
Overall (All Time): #563,543 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
10689394 Thieno[2,3-b]pyridine derivative, quinoline derivative, and use thereof Kengo Homma, Naomi Tsuburaya, Tetsuo Nagano, Takayoshi Okabe, Hirotatsu Kojima +7 more 2020-06-23
7390625 Apoptosis-associated protein and use thereof 2008-06-24
6194187 Apoptosis-inducing protein and gene encoding the same Kohei Miyazono 2001-02-27
6030795 Recombinant TGF-.beta. type I receptor variants having differentially diminished capacity to signal for matrix protein production Masae Saitoh, Kohei Miyazono 2000-02-29
5968752 Method for identifying an OP-1 analog which binds an ALK-1 receptor Hideki Nishitoh, Kuber T. Sampath 1999-10-19
5928940 Morphogen-responsive signal transducer and methods of use thereof Kuber T. Sampath, Kohsuke Takeda 1999-07-27
5731200 Isolated nucleic acid encoding receptor-like TGF-.beta.1 binding protein Kohei Miyazono, Lars Ronnstrand, Ulf Hellman, Christer Wernstedt, Carl-Henrik Heldin 1998-03-24
5578703 Substantially pure receptor like TFG-.beta.1 binding molecules Kohei Miyazono, Lars Ronnstrand, Ulf Hellman, Christer Wernstedt, Carl-Hendrik Heldin 1996-11-26
5229495 Substantially pure receptor like TGF-.beta. 1 binding molecules and uses thereof Kohei Miyazono, Lars Ronnstrand, Ulf Hellman, Christer Wernstedt, Carl-Henrik Heldin 1993-07-20